STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The Company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers minimally invasive intraocular lenses (IOLs), including foldable IOLs for use in minimally invasive cataract surgical procedures; aspheric IOLs that produce a clearer image than traditional spherical lenses; and nanoFLEX IOL, a single piece collamer aspheric optic, as well as preloaded injectors for use in cataract surgery.
Type
Public
HQ
Monrovia, US
Founded
1982
Size (employees)
336 (est)
Website
staar.com
STAAR Surgical was founded in 1982 and is headquartered in Monrovia, US
Report incorrect company information

STAAR Surgical Office Locations

STAAR Surgical has offices in Tustin, Nidau and Monrovia
Monrovia, US (HQ)
1911 Walker Ave
Nidau, CH
104 Hauptstrasse
Show all (3)
Report incorrect company information

STAAR Surgical Financials and Metrics

STAAR Surgical Financials

STAAR Surgical's revenue was reported to be $90.61 m in FY, 2017
USD

Revenue (Q1, 2018)

27.1 m

Gross profit (Q1, 2018)

19.4 m

Gross profit margin (Q1, 2018), %

71.7%

Net income (Q1, 2018)

583 k

EBIT (Q1, 2018)

799 k

Market capitalization (14-Jun-2018)

1.2 b

Closing share price (14-Jun-2018)

29.8
STAAR Surgical's current market capitalization is $1.2 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

72.2 m75 m77.1 m82.4 m90.6 m

Revenue growth, %

4%3%7%

Cost of goods sold

21.9 m26.2 m24.4 m24.1 m26.3 m

Gross profit

50.3 m48.8 m52.7 m58.4 m64.3 m
Quarterly
USDQ3, 2013Q3, 2014Q1, 2015Q2, 2014Q3, 2015Q1, 2015Q2, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Revenue

17.1 m18.2 m20.2 m20 m18.8 m18.9 m18.7 m19.3 m21 m20.1 m20.4 m21.9 m27.1 m

Cost of goods sold

5 m6.3 m6.3 m6.4 m6 m6 m6.3 m6.3 m6.3 m5.2 m5.8 m6.5 m7.7 m

Gross profit

12.1 m11.9 m13.9 m13.7 m12.8 m12.9 m12.4 m13 m14.6 m14.9 m14.6 m15.5 m19.4 m

Gross profit Margin, %

70%65%69%68%68%68%66%67%70%74%72%71%72%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

23 m13 m13.4 m14 m

Accounts Receivable

10.7 k11.1 k15.7 k16.3 k

Inventories

12.5 k15.7 k15.9 k14.8 m

Current Assets

50.1 m44.9 m49.1 m49.9 m
Quarterly
USDQ3, 2013Q3, 2014Q1, 2015Q2, 2014Q3, 2015Q1, 2015Q2, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Cash

23.4 m18.4 m21.1 m19.2 m16.1 m10.8 m15.3 m9 m12.7 m14.3 m13.5 m13.4 m

Inventories

11.9 m15.7 m13.8 m14.9 m14.6 m15.3 m14.2 m16 m15.7 m15.9 m14.6 m13.5 m

Current Assets

47.9 m49.4 m51.1 m50.7 m48.1 m43 m46.6 m46.2 m48.9 m49.7 m49 m47.8 m62.1 m

PP&E

6.5 m9.3 m8.8 m9.3 m9.9 m9.9 m9.9 m11 m11.4 m11.7 m12.1 m11.6 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

398 k(8.4 m)(6.5 m)(12.1 m)(2.1 m)

Depreciation and Amortization

1.7 m2.1 m2.2 m2.7 m3.1 m

Inventories

(1.6 m)(3.9 m)327 k1.8 m312 k

Accounts Payable

367 k972 k14 k1 m(2.5 m)
Quarterly
USDQ3, 2013Q3, 2014Q1, 2015Q2, 2014Q3, 2015Q1, 2015Q2, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

525 k(2.7 m)(1.4 m)(1.8 m)(1.8 m)(2.3 m)(1.6 m)(8 m)(2.1 m)(1.8 m)(2.2 m)583 k

Depreciation and Amortization

549 k

Inventories

(396 k)

Accounts Payable

6.3 m5.3 m5.8 m4.9 m4.8 m6.9 m8.7 m8 m7.6 m2 m
Show all financial metrics

STAAR Surgical Operating Metrics

FY, 2016

Patents Issued

67

Patents Pending

20

Trademarks

11
Show all operating metrics

STAAR Surgical Revenue Breakdown

Embed Graph

STAAR Surgical revenue breakdown by geographic segment: 80.6% from Other countries (the US, Germany, Canada, the UK, etc) and 19.4% from Shanghai Langsheng

Report incorrect company information

STAAR Surgical Online and Social Media Presence

Embed Graph
Report incorrect company information